Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

8 Jun 2017 07:00

RNS Number : 4739H
Sopheon PLC
08 June 2017
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

At today's Annual General Meeting of Sopheon, the international provider of software and services that help organizations generate more revenues and profits from new products, the Board will give shareholders an update and review of the business.

 

It gives us great pleasure to report another year of excellent financial and operational progress, as we continue to advance our strategy of being the world's leading solution provider of enterprise-class innovation management software solutions. A year ago we were pleased to report solid strategic and financial progress, and we are delighted to say the same applies today, one year later. Last year we grew revenues to $23.2m from $20.9m in 2015 and $18.3m in 2014, and we delivered another substantial increase in profitability, with EBITDA rising to $5.2m before exchange gains ($5.6m including exchange gains) from $4.1m the year before, which was itself more than triple the 2014 performance. Profit before tax rose to $3.0m from $1.2m in 2015. In 2016 we also initiated partial recognition of our substantial deferred tax asset, which resulted in a profit after tax of $4.3m. Net assets nearly doubled to $10.4m from $5.5m in 2015.

 

The revenue growth was underpinned by a rise to 49 license transactions from 42 the year before, of which 17 were new customers, up from 14 in 2015. We continued to invest in and show traction with the two elements of our go-to-market strategy - both the global end-to-end enterprise solution, and the "out-of-the-box" Accolade Express solution for quicker time to value. Our market strength in the consumer products industry was again recognized, with Sopheon being voted a "top ten software vendor" for the seventh consecutive year by the CGT magazine readership. In addition to this progress, we also saw strong traction in the aerospace and defense and chemicals sectors. Sopheon's commercial success is being achieved in parallel with strategic and operational initiatives aimed at underpinning our continued growth for the next three to five years. We maintained our rapid pace of product development releases, with another three in 2016, further advancing our platform for enterprise utilization and flexibility, followed by version 11.1 which we released in February this year. 

 

This continued investment supports our growth strategy in two areas. One is to capitalize on existing client demand to expand their Accolade investment beyond product innovation to support Enterprise Initiative Management tracking and decision making. This market opportunity has been validated by Gartner's 2016 Market Guide for Strategy Execution Software and their recognition of Sopheon in this emerging space. We are also delighted to announce Sopheon's inclusion in Gartner's Magic Quadrant for Project Portfolio Management, just last week. Sopheon is the only vendor referenced in both the Market Guide for Strategy Execution Software and the Magic Quadrant for Project Portfolio Management. In Sopheon's view, this provides strong validation of our unique position and strength in the enterprise portfolio management, enterprise initiative management, and product development markets. The second growth area we continue to invest in is our vertical industry focus on chemical, consumer goods, food and beverage, aerospace and defense, and high-tech. In addition, we are researching the insurance, service and automobile industries as we have recently signed customers in these areas. Such customers help us to understand the value proposition Accolade can bring to new vertical markets, and to determine if these represent further new growth opportunities for the Company.

 

Following several years of clarifying our debt, equity and listing structure, our corporate activity has been relatively quiet in the past year, other than extension of the maturity of our debt facilities to January 2019.

 

Sopheon has a market-leading solution, global reach, solid financials, a clear corporate structure, an accelerating market, and most importantly great people - a real platform for growth. Full year revenue visibility for 2017 from contracted business and recurring revenue streams is now at $17.5m, compared to just under $17.0m at this time last year. This includes 20 license orders, up from 14 for the same period last year. This is a different mix compared to this time last year, which included a very substantial order from an existing enterprise tier customer. This is further evidence of the increased adoption of the Company's software and services from a broader range of businesses, including several with expected upside revenue later this year. Sopheon also continues its focus on working with and growing relationships with global blue chip customers such as Electrolux, PepsiCo, Proctor & Gamble and Merck. These factors, together with a strong sales pipeline, give the Board confidence in meeting our strategic and financial plans for the year, and in delivering continued positive development in our performance for 2017 and beyond.

 

 

 

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (corporate finance)

Mia Gardener (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFERRRIDIID
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.